Innovative, Non-Invasive Technologies Advanced Earlier Detection & Monitoring of Liver Disease -
by Jon Gingrich, CEO, Echosens North America Jon Gingrich, CEO, Echosens North America Leveraging technological advances to facilitate new ways of engaging patients and integrating non-invasive technology into a liver disease program not only serves to improve individual outcomes and reduce costs but also strengthens the financial performance of health systems and provider organizations that include this approach to testing. At a time when America’s hospitals and physician groups face lost revenues due to the COVID-19 pandemic, there is a pressing need for reducing costs while maintaining h...
Source: hitconsultant.net